Search

You searched for "diabetes"

684 results found

Cavernous sinus thrombosis and orbital cellulitis

1 August 2019 | | EYE - Neuro-ophthalmology
This is a report of six cases of combined orbital cellulitis and infective cavernous sinus thrombosis, with a literature review. The average age was 39 years, four were male and two were intravenous drug users. All had sinusitis, usually involving...
Case Reports in Ophthalmology cover image

Silicone oil migration presenting as an eyelid cyst

5 August 2020 | | EYE - Paediatrics, EYE - Strabismus
The author presents a single case report of a rare complication of silicone oil tamponade, silicone oil migration, after pars plana vitrectomy. A seven-year-old female, with a history of vitrectomy one year prior for penetrating eye trauma, presented with a...
Seminars in Ophthalmology journal cover image

Intravitreal Ziv-Aflibercept: safety analysis

7 December 2020 | | EYE - Vitreo-Retinal
Ziv-Aflibercept (Zaltrap; Sanofi-Aventis U.S LLS, Bridgewater, NJ) was originally introduced as an intravenous formulation for metastatic colorectal cancer. The adoption of Ziv-Aflibercept in ophthalmic practice was similar to bevacizumab, and reports have previously examined one to two year visual outcomes...

Does religious fasting affect intraocular pressure or retinal parameters?

1 December 2022 | | EYE - Neuro-ophthalmology | Religious fasting, Retina, macula, optical coherence tomography angiography
Nearly one billion Muslims fast every year during the month of Ramadan. Due to the difference between the lunar and solar calendars, religious fasting time can range from 11 to 17 hours per day. This prolonged abstinence from food and...

Efficacy of BT as a treatment for cranial nerve palsy in acute and chronic cases

4 December 2024 | | EYE - Paediatrics, EYE - Strabismus
The authors performed a meta-analysis of all patients’ treatment with botulinum toxin (BT) for cranial nerve palsy (CNP) to determine the efficacy of BT in the treatment of CNP due to a variety of causes. The search identified 1129 articles...

Binocular Indirect Ophthalmoscopy Training Workshop – NHS Fife, Scotland

22 April 2025 | Research & Development
Join leading ophthalmology educator Dr. Andrew Blaikie for a one-day BIO Workshop at FORGE, Queen Margaret Hospital, Dunfermline. This hands-on course using the new Arclight BIO is ideal for ophthalmology trainees. Learn to examine retinal disease, including diabetic retinopathy and...

Telemedicine strategies in ophthalmology: harnessing established and emerging technologies for lasting solutions

7 December 2020 | | EYE - Vitreo-Retinal, EYE - Imaging, EYE - Oculoplastic, EYE - General
The author considers recent progress and shares insights from leading practitioners in telemedicine applications and digital technology strategies. Amidst COVID-19 and combined mitigation and suppression measures, hospitals and clinics have responded rapidly to strengthen telemedicine strategies and virtual healthcare services...

Q&A: Mr Goel and Mr Loomba on alcohol delamination and phototherapeutic keratectomy (PTK) for the treatment of recurrent corneal erosion syndrome

14 June 2023 | | EYE - Cornea
Recurrent corneal erosion syndrome is a common, recurrent condition caused by abnormal epithelial adhesion to the underlying basal lamina. Spontaneous breakdown of the corneal epithelium can lead to the sudden onset of ocular pain, blurred vision, tearing and photophobia, typically...

PREVIEW: RCOphth Annual Congress 2025 #EyeConUK

19 May 2025 | | RCOphth, RCOphth 2025, Annual Congress, EyeConUK, Events, Meetings, Royal College of Ophthalmologists
That time of year is coming around again and the ophthalmic community are ironing their ties and polishing their shoes ready for the Royal College of Ophthalmologists’ Annual #EyeConUK Congress 2025, taking place at the ACC, Liverpool, between 19–22 May....

Broadening of treatment options for potentially blinding retinal conditions

2 August 2022 | | EYE - General
Rod McNeil provides an update on a promising bispecific antibody recently approved for treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular oedema (DMO) and considers emerging developments in biosimilars to established anti-vascular endothelial growth factor (anti-VEGF) therapies, including...

Eye Capacity: clinical need should drive ophthalmic service provision

1 February 2014 |
Almost two million people in the UK suffer sight loss, a number forecast to double over coming decades. Major causes of blindness are age-related macular degeneration (AMD), glaucoma, diabetic retinopathy, cataract and uncorrected refractive error. Prevalence of these sight-threatening conditions...

Time is vision in central retinal artery occlusion

4 August 2021 | | EYE - Vitreo-Retinal, EYE - General
Central retinal artery occlusion (CRAO) is a rare but devastating vascular episode that can have severe impact on vision. Treatment is very time-limited and needs to be initiated very quickly to salvage any vision. The majority of patients present to...